CHRM1 and glioblastoma: TIMER2.0 web tools [11] indicated that gene correlation between EGFR expression and genes associated with mAChRs (CHRM1–5) was not significant in GBM patients; the Gene Outcome module indicated that survival of these genes was not significant either, and the Immune Module showed that immune infiltration level in GBM was not significant.